Esperion Therapeutics(美國(guó))

Esperion Therapeutics

EsperionTherapeuticswww.esperion.com生物制藥公司，專注于研究，開(kāi)發(fā)和商業(yè)化的低密度脂蛋白膽固醇（LDL-C）水平升高和其他心血管代謝危險(xiǎn)因素的患者的治療療法。EsperionTherapeutics,Inc.isaleaderinthedevelopmentandcommercializationoforal,smallmoleculetherapiesfort hetreatmentofpatientswithelevatedlevelsoflow-densitylipoproteincholesterol(LDL-C)andothercardiometabolicriskfactors.ETC-1002,Esperion’sleadproductcandidate,isanovel,first-in-class,orallyavailable,once-dailyLDL-CloweringsmallmoleculetherapydesignedtotargetknownlipidandcarbohydratemetabolicpathwaystolowerlevelsofLDL-CandtoavoidmanyofthesideeffectsassociatedwithexistingLDL-Cloweringtherapies.ETC-1002istargetedforstatin-intolerantpatientswithelevatedlevelsofLDL-C.